Optalidon | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Optalidon
Canada

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Optalidon

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 8 USDMF, 9 NDC API, 2 Listed Suppliers, $ API Reference Price

9 API Suppliers
8 USDMF
9 NDC API
2 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

129 FDF Dossiers, 113 FDA Orange Book, 8 Canada, 8 Listed Dossiers

129 FDF Dossiers
113 FDA Orange Book
8 Canada
8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 325MG;50MG;40MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET;ORAL - 325MG;50MG;40MG
TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Rochem International Inc, 7 SPI Pharma, 12 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 30 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 30 Roquette, 8 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

75 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 31 Thickeners and Stabilizers, 29 Direct Compression, 28 Controlled & Modified Release, 28 Granulation, 24 Lubricants & Glidants, 18 Taste Masking, 18 Film Formers & Plasticizers, 15 Solubilizers, 14 Topical, 12 Chewable & Orodispersible Aids, 12 Parenteral, 11 Co-Processed Excipients, 9 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

75 Fillers, Diluents & Binders
51 Coating Systems & Additives
40 Disintegrants & Superdisintegrants
31 Thickeners and Stabilizers
29 Direct Compression
28 Controlled & Modified Release
28 Granulation
24 Lubricants & Glidants
18 Taste Masking
18 Film Formers & Plasticizers
15 Solubilizers
14 Topical
12 Chewable & Orodispersible Aids
12 Parenteral
11 Co-Processed Excipients
9 Empty Capsules
5 Coloring Agents
5 Emulsifying Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 API Stability Enhancers
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

27 News #PharmaBuzz

27 News #PharmaBuzz

MARKET PLACE

1 APIs

1 APIs

REF. STANDARDS & IMPURITIES

1 USP, 4 Others

1 USP
4 Others

$ API Ref.Price (USD/KG) : 1,017 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 3ARALEZ PHARMACEUTICALS CANADA INC

02 1LABORATOIRE RIVA INC.

03 4TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

8 All

01 8BUTALBITAL

filter Dosage Form Reset all filters

8 All

01 6CAPSULE

02 2TABLET

filter Brand Name Reset all filters

8 All

01 1FIORINAL

02 1FIORINAL-C 1/2

03 1FIORINAL-C 1/4

04 2TEVA-TECNAL

05 1TEVA-TECNAL C 1/2

06 1TEVA-TECNAL C 1/4

07 1TRIANAL TABLET

List of Suppliers

Product Main Page

01

ARALEZ PHARMACEUTICALS CANADA INC

BioTrinity 2025

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : FIORINAL-C 1/4

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100

Approval Date :

Application Number : 176192

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ARALEZ PHARMACEUTICALS CANADA INC

BioTrinity 2025

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Brand Name : FIORINAL

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 226327

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ARALEZ PHARMACEUTICALS CANADA INC

BioTrinity 2025

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : FIORINAL-C 1/2

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number : 176206

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Brand Name : TEVA-TECNAL

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number : 608211

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Brand Name : TEVA-TECNAL

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number : 608238

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : TEVA-TECNAL C 1/4

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number : 608203

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

TEVA CANADA LIMITED

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Brand Name : TEVA-TECNAL C 1/2

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number : 608181

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

LABORATOIRE RIVA INC.

Country

BioTrinity 2025

Not Confirmed

LABORATOIRE RIVA INC.

Country

BioTrinity 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Brand Name : TRIANAL TABLET

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number : 1971409

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!